AB
IART icon

Amalgamated Bank’s Integra LifeSciences IART Stock Holding History

Amalgamated Bank’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Sell
19,286
-104
-0.5% -$1.14K ﹤0.01% 1576
2025
Q4 		$241K Sell
19,390
-419
-2% -$5.57K ﹤0.01% 1520
2025
Q3 		$284K Buy
19,809
+728
+4% +$9.97K ﹤0.01% 1479
2025
Q2 		$234K Hold
19,081
– – ﹤0.01% 1514
2025
Q1 		$420K Sell
19,081
-313
-2% -$7.36K ﹤0.01% 1315
2024
Q4 		$440K Sell
19,394
-478
-2% -$10.4K ﹤0.01% 1344
2024
Q3 		$361K Sell
19,872
-1,082
-5% -$25.1K ﹤0.01% 1418
2024
Q2 		$611K Sell
20,954
-24,149
-54% -$716K 0.01% 1228
2024
Q1 		$1.6M Buy
45,103
+533
+1% +$21.3K 0.01% 920
2023
Q4 		$1.94M Buy
44,570
+98
+0.2% +$3.86K 0.02% 925
2023
Q3 		$1.7M Sell
44,472
-2,155
-5% -$90.7K 0.01% 932
2023
Q2 		$1.92M Sell
46,627
-3,289
-7% -$158K 0.02% 908
2023
Q1 		$2.87M Sell
49,916
-6,859
-12% -$386K 0.02% 728
2022
Q4 		$3.18M Buy
56,775
+4,825
+9% +$246K 0.03% 716
2022
Q3 		$2.2M Buy
51,950
+683
+1% +$35K 0.02% 797
2022
Q2 		$2.77M Buy
51,267
+984
+2% +$59.1K 0.03% 738
2022
Q1 		$3.23M Sell
50,283
-1,835
-4% -$121K 0.03% 715
2021
Q4 		$3.49M Sell
52,118
-882
-2% -$59.7K 0.03% 698
2021
Q3 		$3.63M Sell
53,000
-4,348
-8% -$307K 0.03% 668
2021
Q2 		$3.91M Buy
57,348
+48,449
+544% +$3.43M 0.03% 667
2021
Q1 		$615K Sell
8,899
-591
-6% -$40K 0.02% 865
2020
Q4 		$616K Buy
9,490
+21
+0.2% +$1.13K 0.02% 845
2020
Q3 		$447K Sell
9,469
-39
-0.4% -$1.85K 0.02% 903
2020
Q2 		$447K Sell
9,508
-6,488
-41% -$319K 0.02% 894
2020
Q1 		$715K Sell
15,996
-357
-2% -$18.7K 0.02% 738
2019
Q4 		$953K Buy
16,353
+1,713
+12% +$102K 0.02% 819
2019
Q3 		$879K Sell
14,640
-244
-2% -$14.5K 0.02% 798
2019
Q2 		$831K Sell
14,884
-1,431
-9% -$73.7K 0.02% 829
2019
Q1 		$909K Buy
16,315
+219
+1% +$11.2K 0.02% 749
2018
Q4 		$726K Buy
16,096
+4,813
+43% +$264K 0.02% 775
2018
Q3 		$743K Sell
11,283
-5,571
-33% -$346K 0.02% 804
2018
Q2 		$1.09M Buy
16,854
+7,714
+84% +$478K 0.03% 721
2018
Q1 		$506K Sell
9,140
-160
-2% -$8.39K 0.01% 955
2017
Q4 		$445K Buy
9,300
+557
+6% +$27.3K 0.01% 1046
2017
Q3 		$441K Buy
8,743
+233
+3% +$12K 0.01% 1005
2017
Q2 		$464K Buy
8,510
+524
+7% +$25K 0.02% 989
2017
Q1 		$336K Sell
7,986
-22
-0.3% -$940 0.02% 1066
2016
Q4 		$344K Buy
8,008
+1,036
+15% +$42.1K 0.02% 1057
2016
Q3 		$288K Buy
6,972
+16
+0.2% +$670 0.02% 1040
2016
Q2 		$292K Buy
6,956
+920
+15% +$33.1K 0.02% 1034
2016
Q1 		$203K Buy
+6,036
New +$188K 0.02% 1141

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amalgamated Bank's IART Position: Q1 2026 in Review

Amalgamated Bank reduced its Integra LifeSciences (IART) stake by 0.54% in Q1 2026, selling an estimated $1.14K and leaving 19,286 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Amalgamated Bank first reported a position in IART in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.91M in Q2 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Amalgamated Bank held 19,286 shares of Integra LifeSciences worth $182K as of Q1 2026.
  • Amalgamated Bank sold 104 Integra LifeSciences shares in Q1 2026, an estimated $1.14K.
  • Integra LifeSciences made up ﹤0.01% of Amalgamated Bank's portfolio in Q1 2026, its #1576 holding.
  • Amalgamated Bank first reported a position in Integra LifeSciences in Q1 2016 and has held it in 41 quarters since.
  • Amalgamated Bank's Integra LifeSciences position peaked at $3.91M in Q2 2021.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.